As a mouse model of MSD, a Sumf1−/− strain has been developed, displaying a complete loss of sulfatase activities, early mortality, congenital growth retardation, skeletal abnormalities, neurological defects, and a generalized inflammatory process affecting various organs [56]. This evidence concerns the gene SUMF1 and mucosulfatidosis.